Revvity
RVTYAlgoritmens signaler
- ›Starkt 3m-momentum (+44.0%)
- ›Starkt 6m-momentum (+66.8%)
- ›Starkt 12m-momentum (+70.7%)
- ›Pris över MA50 och MA200 (uppåttrend)
- ›+79% från 52v-botten
- ›Ökad handelsvolym (+46%)
📰 Senaste nyheter & analys
Källor: Placera, Nyhetsbyrån Direkt, Google NewsRevvity (RVTY) Stock May Be Fairly Priced Following A Cell Model Deal - simplywall.st
6 h sedanRevvity (RVTY) Stock May Be Fairly Priced Following A Cell Model Deal simplywall.st
simplywall.stHere’s How Much You Would Have Made Owning Revvity Stock In The Last 15 Years - Benzinga
7 h sedanHere’s How Much You Would Have Made Owning Revvity Stock In The Last 15 Years Benzinga
BenzingaRevvity (NYSE: RVTY) executive plans $1M stock sale - stocktitan.net
15 h sedanRevvity (NYSE: RVTY) executive plans $1M stock sale stocktitan.net
stocktitan.netStrength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength? - finance.yahoo.com
19 h sedanStrength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength? finance.yahoo.com
finance.yahoo.comRevvity extends gains with another 9% advance, sets new high (RVTY:NYSE) - Seeking Alpha
1 d sedanRevvity extends gains with another 9% advance, sets new high (RVTY:NYSE) Seeking Alpha
Seeking AlphaWhy Revvity (RVTY) Stock Is Up Today - Quiver Quantitative
1 d sedanWhy Revvity (RVTY) Stock Is Up Today Quiver Quantitative
Quiver QuantitativeStocks making the biggest moves midday: Skyworks Solutions, Axon, Dave & Buster's, Revvity & more - CNBC
1 d sedanStocks making the biggest moves midday: Skyworks Solutions, Axon, Dave & Buster's, Revvity & more CNBC
CNBCQ2 Rundown: Revvity (NYSE:RVTY) Vs Other Research Tools & Consumables Stocks - StockStory
2 d sedanQ2 Rundown: Revvity (NYSE:RVTY) Vs Other Research Tools & Consumables Stocks StockStory
StockStoryRevvity handlas exklusive utdelning i dag
2026-07-17Revvity handlas i dag exklusive rätt till utdelning med 0,07 dollar per aktie.Det framgår av Factset.Merima TikvesaNyhetsbyrån Finwire
RevvityFinwireRevvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes
2025-10-02Revvity, Inc. (NYSE: RVTY) today announced a program for expansion of its type 1 diabetes (T1D) offering to include a population-scale assay for early detection with support from Sanofi (EURONEXT: SAN
RevvityBusiness WireRevvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis
2025-09-29Today Revvity, Inc. (NYSE: RVTY), announced the launch of its Living Image™ Synergy AI multimodal analysis software for in vivo imaging researchers. The solution provides a unified platform with AI ca
RevvityBusiness WireRevvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems
2025-09-22Revvity, Inc. (NYSE: RVTY) announced a strategic collaboration with Profluent, bringing together a range of its novel AI-engineered enzymes with Revvity’s established Pin-pointTM base editing platform
RevvityBusiness WireRevvity Establishes In Vivo Imaging Center of Excellence in North Carolina
2025-09-02Revvity, Inc. (NYSE: RVTY), today announced the opening of its new In Vivo Imaging Center of Excellence in Morrisville, North Carolina, the heart of the state’s Research Triangle. The center consolida
RevvityBusiness WireRevvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows
2025-06-02Revvity, Inc. (NYSE: RVTY), today announced the launch of three Mimix™ reference standards for IVD use, designed for monitoring of next-generation sequencing (NGS) or droplet digital polymerase chain
RevvityBusiness WireRevvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test
2025-04-02Revvity, Inc. (NYSE: RVTY), today announced that the U.S. Food and Drug Administration (FDA) has approved the Auto-Pure 2400 liquid handling platform with the T-SPOT™.TB test. Initially launched outsi
RevvityBusiness WireRevvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing
2025-01-13Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc.,
RevvityBusiness Wire
Klicket på "Köp i Nordnet" öppnar din Nordnet-app om installerad — där loggar du in med BankID. Annars öppnas Nordnets webbsajt där du kan logga in med BankID på samma sätt.